X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (21) 21
humans (19) 19
cardiac & cardiovascular systems (18) 18
male (14) 14
cardiovascular (13) 13
female (13) 13
aged (12) 12
abridged index medicus (10) 10
cardiac patients (9) 9
middle aged (9) 9
treatment outcome (9) 9
cardiology (7) 7
heart attacks (7) 7
percutaneous coronary intervention (7) 7
acute coronary syndromes (6) 6
coronary angiography (6) 6
electrocardiography (6) 6
mortality (6) 6
acute myocardial-infarction (5) 5
angiography (5) 5
care and treatment (5) 5
follow-up studies (5) 5
optical coherence tomography (5) 5
percutaneous coronary intervention - methods (5) 5
time factors (5) 5
trial (5) 5
angioplasty (4) 4
coronary heart disease (4) 4
coronary vessels (4) 4
hirudins - administration & dosage (4) 4
intervention (4) 4
medical imaging (4) 4
myocardial infarction - therapy (4) 4
peptide fragments - administration & dosage (4) 4
percutaneous coronary intervention - adverse effects (4) 4
platelet glycoprotein gpiib-iiia complex - antagonists & inhibitors (4) 4
prospective studies (4) 4
recombinant proteins - administration & dosage (4) 4
single-blind method (4) 4
stents (4) 4
thrombectomy (4) 4
acute coronary syndrome - surgery (3) 3
acute kidney injury - chemically induced (3) 3
acute myocardial infarction (3) 3
analysis (3) 3
angina pectoris (3) 3
angioplasty, balloon, coronary - adverse effects (3) 3
antibodies, monoclonal - administration & dosage (3) 3
anticoagulants - administration & dosage (3) 3
cardiology and cardiovascular medicine (3) 3
cardiovascular disease (3) 3
clinical trials (3) 3
clopidogrel (3) 3
contrast media - adverse effects (3) 3
coronary angiography - adverse effects (3) 3
coronary angiography - methods (3) 3
heart attack (3) 3
heparin - administration & dosage (3) 3
immunoglobulin fab fragments - administration & dosage (3) 3
internal medicine (3) 3
iohexol - adverse effects (3) 3
iohexol - analogs & derivatives (3) 3
metaanalysis (3) 3
myocardial infarction - diagnostic imaging (3) 3
outcomes (3) 3
platelet aggregation inhibitors - administration & dosage (3) 3
platelet aggregation inhibitors - therapeutic use (3) 3
prevention (3) 3
primary angioplasty (3) 3
reperfusion (3) 3
risk (3) 3
risk factors (3) 3
st-segment elevation (3) 3
thrombectomy - adverse effects (3) 3
thrombectomy - methods (3) 3
thrombosis (3) 3
transluminal angioplasty (3) 3
triiodobenzoic acids - adverse effects (3) 3
acute coronary syndrome (2) 2
acute coronary syndrome - complications (2) 2
acute coronary syndrome - mortality (2) 2
acute kidney injury - blood (2) 2
administration, oral (2) 2
adult (2) 2
angioplasty, balloon, coronary - methods (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antithrombins - administration & dosage (2) 2
antithrombins - adverse effects (2) 2
artery-disease (2) 2
autonomic nervous system (2) 2
bleeding (2) 2
blood clots (2) 2
clinical-applications (2) 2
comparative analysis (2) 2
contrast media (2) 2
coronary artery disease - therapy (2) 2
coronary circulation (2) 2
coronary restenosis - diagnosis (2) 2
coronary thrombosis - diagnostic imaging (2) 2
creatinine (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9986, pp. 2465 - 2476
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 170, Issue 6, pp. 1116 - 1123
Background Thrombus burden and distal embolization are predictive of no-reflow during primary percutaneous coronary intervention (PCI) in patients with acute... 
Cardiovascular | MORTALITY | PERCUTANEOUS CORONARY INTERVENTION | CARDIAC & CARDIOVASCULAR SYSTEMS | NO-REFLOW | OPTICAL COHERENCE TOMOGRAPHY | RATIONALE | PLATELET | REPERFUSION | IMPROVES | INTRAVENOUS BOLUS ABCIXIMAB | THROMBUS-ASPIRATION | Humans | Immunoglobulin Fab Fragments - adverse effects | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Coronary Restenosis - diagnosis | Coronary Angiography - methods | Percutaneous Coronary Intervention - methods | Thrombectomy - methods | No-Reflow Phenomenon - etiology | Female | Thrombosis - therapy | Coronary Restenosis - etiology | Myocardial Infarction - diagnosis | No-Reflow Phenomenon - diagnosis | Postoperative Complications - therapy | Treatment Outcome | Thrombectomy - adverse effects | Tomography, Optical Coherence - methods | Coronary Restenosis - therapy | Myocardial Reperfusion - methods | Postoperative Complications - diagnosis | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Myocardial Infarction - complications | Immunoglobulin Fab Fragments - administration & dosage | Antibodies, Monoclonal - administration & dosage | Thrombosis - etiology | Platelet Aggregation Inhibitors | No-Reflow Phenomenon - therapy | Aged | Percutaneous Coronary Intervention - adverse effects | Thrombosis - diagnosis | Care and treatment | Analysis | Cardiac patients | Heart attack | Tomography | Heart attacks | Angioplasty | Catheters | Blood clots
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2012, Volume 109, Issue 1, pp. 67 - 74
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2015, Volume 115, Issue 10, pp. 1351 - 1356
Journal Article
Journal Article
JACC: Cardiovascular Imaging, ISSN 1936-878X, 2015, Volume 8, Issue 11, pp. 1297 - 1305
Abstract Objectives The goal of this study was to assess the clinical impact of optical coherence tomography (OCT) findings during percutaneous coronary... 
Cardiovascular | registry | percutaneous coronary intervention | clinical outcome | optical coherence tomography
Journal Article
American Heart Journal, ISSN 0002-8703, 2009, Volume 158, Issue 4, pp. e59 - e59
  [...]DES thrombosis rate after dual antiplatelet therapy discontinuation is not trivial, occurring in 0.4% to 0.6% patients per year as the above mentioned... 
Cardiovascular | TRIAL | RISK | CARDIAC & CARDIOVASCULAR SYSTEMS | ASPIRIN | Coronary Restenosis - prevention & control | Treatment Outcome | Ticlopidine - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Humans | Ticlopidine - analogs & derivatives | Aspirin | Heart attacks | Drug therapy | Angina pectoris | Thrombosis
Journal Article
by Valgimigli, Marco and Frigoli, Enrico and Leonardi, Sergio and Vranckx, Pascal and Rothenbühler, Martina and Tebaldi, Matteo and Varbella, Ferdinando and Calabrò, Paolo and Garducci, Stefano and Rubartelli, Paolo and Briguori, Carlo and Andó, Giuseppe and Ferrario, Maurizio and Limbruno, Ugo and Garbo, Roberto and Sganzerla, Paolo and Russo, Filippo and Nazzaro, Marco and Lupi, Alessandro and Cortese, Bernardo and Ausiello, Arturo and Ierna, Salvatore and Esposito, Giovanni and Ferrante, Giuseppe and Santarelli, Andrea and Sardella, Gennaro and de Cesare, Nicoletta and Tosi, Paolo and van 't Hof, Arnoud and Omerovic, Elmir and Brugaletta, Salvatore and Windecker, Stephan and Heg, Dik and Jüni, Peter and Campo, Gianluca and Uguccioni, Lucia and Tamburino, Corrado and Presbitero, Patrizia and Zavalloni-Parenti, Dennis and Ferrari, Fabio and Ceravolo, Roberto and Tarantino, Fabio and Pasquetto, Giampaolo and Casu, Gavino and Mameli, Stefano and Stochino, Maria Letizia and Mazzarotto, Pietro and Cremonesi, Alberto and Saia, Francesco and Saccone, Giovanni and Abate, Fabio and Picchi, Andrea and Violini, Roberto and Colangelo, Salvatore and Boccuzzi, Giacomo and Guiducci, Vincenzo and Vigna, Carlo and Zingarelli, Antonio and Gagnor, Andrea and Zaro, Tiziana and Tresoldi, Simone and Vandoni, Pietro and Contarini, Marco and Liso, Armando and Dellavalle, Antonio and Curello, Salvatore and Mangiacapra, Fabio and Evola, Rosario and Palmieri, Cataldo and Falcone, Camillo and Liistro, Francesco and Creaco, Manuela and Colombo, Antonio and Chieffo, Alaide and Perkan, Andrea and De Servi, Stefano and Fischetti, Dionigi and Rigattieri, Stefano and Sciahbasi, Alessandro and Pucci, Edoardo and Romagnoli, Enrico and Moretti, Luciano and Moretti, Claudio and De Caterina, Raffaele and Caputo, Marcello and Zimmarino, Marco and Bramucci, Ezio and Di Lorenzo, Emilio and Turturo, Maurizio and Bonmassari, Roberto and Penzo, Carlo and Loi, Bruno and Mauro, Ciro and Petronio, Anna Sonia and Gabrielli, Gabriele and Micari, Antonio and Belloni, Flavia and Amico, Francesco and Comeglio, Marco and Fresco, Claudio and ... and MATRIX Investigators and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
The Lancet, ISSN 0140-6736, 09/2018, Volume 392, Issue 10150, pp. 835 - 848
The Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of Angiox (MATRIX) programme was designed to assess the... 
2017 ESC | SITE | MEDICINE, GENERAL & INTERNAL | ANGIOGRAPHY | METAANALYSIS | MONOTHERAPY | PCI | ACUTE MYOCARDIAL-INFARCTION | INTERVENTION | ARTERY-DISEASE | Perioperative Care | Anticoagulants - administration & dosage | Humans | Middle Aged | Heparin - administration & dosage | Male | Antithrombins - administration & dosage | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Acute Coronary Syndrome - complications | Radial Artery | Percutaneous Coronary Intervention - methods | Female | Femoral Artery | Myocardial Infarction - etiology | Mortality | Peptide Fragments - administration & dosage | Acute Coronary Syndrome - diagnostic imaging | Anticoagulants - adverse effects | Recombinant Proteins - administration & dosage | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Coronary Angiography | Stroke - etiology | Antithrombins - adverse effects | Hirudins - adverse effects | Acute Coronary Syndrome - surgery | Aged | Peptide Fragments - adverse effects | Hemorrhage - chemically induced | Prosthesis Failure - etiology | Stents - adverse effects | Percutaneous Coronary Intervention - adverse effects | Anticoagulants (Medicine) | Coronary heart disease | Analysis | Cardiac patients | Intervention | Myocardial infarction | Short term | Surgical implants | Femur | Heart attacks | Angiography | Medical services | Clinical trials | Antithrombin | Matrix methods | Bleeding | Infusion | Elevation | Randomization | Motivation | Mathematical analysis | Calcium-binding protein | Implants | Cardiology | Thromboembolism | Stents | Cerebral infarction | Stroke | Medical imaging | Coronary artery | Glycoprotein | Glycoproteins | Angina pectoris | Patients | Thrombosis | Troponin | Inhibitors | Clopidogrel | Infarction | Heparin | Acute coronary syndromes | Kardiologi | Cardiac and Cardiovascular Systems
Journal Article